pyranoprofen has been researched along with Disease Exacerbation in 1 studies
pyranoprofen: RN given refers to unlabled parent cpd; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeuchi, A | 1 |
| Nomura, A | 1 |
| Yamamoto, N | 1 |
| Hayashi, K | 1 |
| Igarashi, K | 1 |
| Tandai, S | 1 |
| Kawai, A | 1 |
| Matsumine, A | 1 |
| Miwa, S | 1 |
| Nishida, Y | 1 |
| Nakamura, T | 1 |
| Terauchi, R | 1 |
| Hoshi, M | 1 |
| Kunisada, T | 1 |
| Endo, M | 1 |
| Yoshimura, K | 1 |
| Murayama, T | 1 |
| Tsuchiya, H | 1 |
1 trial available for pyranoprofen and Disease Exacerbation
| Article | Year |
|---|---|
Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol.
Topics: Adult; Aged; Antineoplastic Agents; Benzopyrans; Clinical Trials, Phase II as Topic; Disease Progres | 2019 |